Newsletter

086450 - Dong Kook Pharmaceutical Co., Ltd.

086450 Summary
Biopharma
Stock Price & Overview
₩21,600 -200 (-0.92%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩21,600  ≈ US$15  ·  Market cap ₩1.0tn (≈ $698m)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

086450 DART Filings

DART

Half-Year Report

Periodic08/14/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
1 routine filings (insider holdings reports, IR schedules)DART

5% Ownership Report — Large Holdings

Ownership05/26/26title translated
3 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 086450

SymbolLast Price
127120JS Link₩33,600
+12.4%
475830Orum Therapeutics, Inc.₩55,900
+2.6%
195940HK inno.N Corporation₩42,050
+0.7%
003090Daewoong Co., Ltd.₩16,860
-2.0%
185750Chong Kun Dang Pharmaceutical Corp.₩68,000
-0.3%
115180Qurient Co., Ltd.₩23,050
+17.3%
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
950260Ingenia Therapeutics Inc.(reg.s)₩15,580
-1.5%
085660Chabiotech Co., Ltd.₩8,090
+2.1%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.